Absence of a pharmacokinetic interaction between enalapril and frusemide.
Open Access
- 1 January 1987
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 23 (1) , 84-87
- https://doi.org/10.1111/j.1365-2125.1987.tb03013.x
Abstract
Single doses of enalapril maleate 10 mg and frusemide 80 mg do not significantly affect the pharmacokinetics of each other when taken concomitantly. Their concomitant use may be associated with more adverse effects than with the individual entities.Keywords
This publication has 13 references indexed in Scilit:
- Enalapril (MK421) activation in man: importance of liver status.Published by Wiley ,1985
- Captopril Versus Enalapril MaleateJournal of Cardiovascular Pharmacology, 1985
- Blood pressure, plasma volume, and catecholamine levels during enalapril therapy in blacks with hypertensionClinical Pharmacology & Therapeutics, 1984
- Implications of intraindividual variability in bioavailability studies of furosemideEuropean Journal of Clinical Pharmacology, 1984
- Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluationsJournal of the American College of Cardiology, 1983
- Effects of enalapril, a new converting enzyme inhibitor, in hypertensionClinical Pharmacology & Therapeutics, 1982
- The Use of HPLC to Elucidate the Metabolism and Urinary Excretion of Furosemide and its Metabolic ProductsActa Pharmacologica et Toxicologica, 1981
- ANTIHYPERTENSIVE ACTIVITY OF N-[(S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALA-L-PRO (MK-421), AN ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR1981
- Determining the probability of an important difference in bioavailabilityClinical Pharmacology & Therapeutics, 1980
- Measurement of furosemide by high-performance liquid chromatographyJournal of Chromatography A, 1979